about
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
Read More
15.71
0.34
(2.21%)
16,234
XNAS Volume
XNAS 24 Sep, 2025 11:12 AM (EDT)
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Amarin Corp ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..